News
PolyVascular Awarded $3 Million NIH SBIR Phase IIb Grant to Advance Polymer-Based Pediatric Heart Valve Toward Clinical Trials
Houston, TX — April 24, 2025 — PolyVascular, a pioneering medical device company developing the first polymer-based transcatheter pulmonary valve designed specifically for young children, announced...
PolyVascular to Present Groundbreaking Preclinical Study at CRF’s TCT 2024 Conference
PolyVascular, a pioneering medtech company focused on developing innovative transcatheter valve solutions for children with congenital heart disease, is proud to announce its acceptance to present...
PolyVascular Presents Latest Preclinical In Vivo Study at 2024 Annual PICS Symposium in San Diego, CA.
PolyVascular Presents Latest Preclinical In Vivo Study at 2024 Annual PICS Symposium in San Diego, CA.
PolyVascular Welcomes Steven Girouard, PhD to its Board of Directors
PolyVascular, a pioneering company focused on developing the world’s first polymeric, non-surgical pulmonary valve for pediatric patients, is excited to announce that Steven Girouard, PhD, an...
CobiCure Awards $2 Million Grant to PolyVascular Through New Strategic Collaboration
PolyVascular is excited to announce a strategic collaboration with CobiCure.
PolyVascular Awarded $2 Million Small Business Innovation Research Grant to Bring the First Polymer-Based Heart Valve for Children to Clinical Trials
PolyVascular Hires Will Clifton, MD, as COO to Manage Path to Human Trials in US; Ultimate Goal to Help 1 Million Pediatric Patients With Congenital Heart Disease Around the World With More...
